Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Kymera Therapeutics Inc (KYMR)

Kymera Therapeutics Inc (KYMR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Kymera Therapeutics Inc 200 Arsenal Yards Blvd. Suite 230 Watertown MA 02472 USA

www.kymeratx.com P: 857-285-5300

Description:

Kymera Therapeutics Inc. is a biopharmaceutical company. It is focused on discovering and developing small molecule therapeutics for degrade dysregulated, disease-causing proteins to address previously intractable disease targets. Kymera Therapeutics Inc. is based in Watertown, United States.

Key Statistics

Overview:

Market Capitalization, $K 2,075,974
Enterprise Value, $K 1,966,004
Shares Outstanding, K 61,112
Annual Sales, $ 78,590 K
Annual Net Income, $ -146,960 K
Last Quarter Sales, $ 47,890 K
Last Quarter Net Income, $ -14,370 K
EBIT, $ -165,530 K
EBITDA, $ -167,190 K
60-Month Beta 2.27
% of Insider Shareholders 16.67%
Float, K 50,925
% Float 83.33%
Short Volume Ratio 0.85

Growth:

1-Year Return -1.41%
3-Year Return -24.59%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.25 on 02/22/24
Latest Earnings Date 05/02/24
Earnings Per Share ttm -2.52
EPS Growth vs. Prev Qtr 72.22%
EPS Growth vs. Prev Year 58.33%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

KYMR Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -34.83%
Return-on-Assets % -25.30%
Profit Margin % -187.00%
Debt/Equity 0.00
Price/Sales 27.31
Price/Cash Flow N/A
Price/Book 4.93
Book Value/Share 7.12
Interest Coverage -733.80
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar